Darbepoetin alfa 3.0 mcg/kg every 2 weeks improves hemoglobin and quality of life in a subset of breast cancer patients in a community-based trial of patients with chemotherapy-induced anemia. Blayney, D. W., Vadhan-Raj, S., Mirtsching, B. C., Tomita, D., Colowick, A. KLUWER ACADEMIC PUBL. 2003: S154

View details for Web of Science ID 000186783100488